BFA
AGN

BlackRock Fund Advisors’s Allergan Inc AGN Stock Holding History

BlackRock Fund Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,544,625
Closed -$754M – 3834
2014
Q4 		$754M Buy
3,544,625
+157,996
+5% +$31.4M 0.19% 82
2014
Q3 		$603M Buy
3,386,629
+144,625
+4% +$24M 0.17% 91
2014
Q2 		$549M Sell
3,242,004
-223,783
-6% -$34.8M 0.15% 102
2014
Q1 		$430M Buy
3,465,787
+169,976
+5% +$20.7M 0.13% 126
2013
Q4 		$366M Sell
3,295,811
-15,694
-0.5% -$1.5M 0.11% 148
2013
Q3 		$300M Sell
3,311,505
-86,715
-3% -$7.78M 0.1% 165
2013
Q2 		$286M Buy
+3,398,220
New +$353M 0.11% 166

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BlackRock Fund Advisors's AGN Position: Q1 2015 in Review

BlackRock Fund Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,544,625 shares — an estimated $754M sold.

BlackRock Fund Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $754M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock Fund Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 3,544,625 Allergan Inc shares in Q1 2015, an estimated $754M.
  • BlackRock Fund Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock Fund Advisors's Allergan Inc position peaked at $754M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock Fund Advisors's 13F filing for Q1 2015, filed 13 May 2015.